Start with 0.25mL once weekly, increase to 0.5mL if needed/tolerated
A medication requiring hepatic metabolism is not automatically a toxin, and the metabolic pathway differs according to the compound, dose, genetics, nutrition, liver function and drug interactions
Last week, pharmaceutical giant Eli Lilly announced phase 3 clinical trial results for its big-bet new weight loss drug, retatrutide
The patient presented with sudden, painless visual blurring and a central scotoma, with significant unilateral visual loss a pattern that did not map neatly onto classical NAION or demyelinating optic neuritis
Applying the causal roadmap to longitudinal national registry data: a case study of second-line diabetes medication and dementia